Rare diseases
Investigational molecules
Locations
147 conditions with trials, the busiest first
546 trials across Europe, recruiting first
Study of Ambroxol Treatment in People with Early Stage or Mild Lewy Body Dementia
NorwayStudy of Fecal Microbiota Transplantation in Capsule Form Compared to Placebo for Patients with Severe Irritable Bowel Syndrome
FranceStudy on Biomarkers for Predicting Response to Clozapine in Patients with Schizophrenia
DenmarkStudy on Donepezil Versus Non-drug Treatment for Patients with Alzheimer's Disease
FranceStudy on Rituximab for Patients with Mental Disorders and Autoimmunity
FranceStudy on Cannabidiol as an Add-On Treatment for Patients with Severe Alcohol Use Disorder During Inpatient Alcohol Cessation
FranceStudy of diazepam and oxazepam in patients with benzodiazepine and opioid dependence who are receiving opioid agonist therapy
NorwayStudy on Adding OSU6162 to Treatment for Patients with Depression Resistant to SSRI/SNRI Medications
SwedenA Study of OSU6162 in Adults with Bipolar Depression to Evaluate Safety and Effectiveness
SwedenStudy on Ketamine and Midazolam for Treating Obsessive-Compulsive Disorder in Adults
AustriaStudy on the Effects of Cariprazine on Cognitive Function in Schizophrenia Patients Needing Antipsychotic Treatment Adjustment
AustriaStudy on Valsartan for Slowing Aortic Root Dilatation in Children and Young Adults with Marfan Syndrome and Related Conditions
PolandThe therapies tested most often in Psychiatric disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
